Roche has way to get antibody therapies into brain

the antibodies hit their target, and significantly reduced levels of amyloid beta in the brain. Several companies, including Eli Lilly and Co (LLY.N Lilly pulled the plug on late-stage studies of its gamma-secretase drug semagacestat last summer because...